CC
ABMD

ClearArc Capital’s Abiomed Inc ABMD Stock Holding History

ClearArc Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-747
Closed -$213K – 372
2019
Q1 		$213K Sell
747
-27
-3% -$8.97K 0.06% 356
2018
Q4 		$252K Sell
774
-376
-33% -$131K 0.08% 287
2018
Q3 		$517K Buy
1,150
+63
+6% +$24.8K 0.07% 272
2018
Q2 		$445K Buy
+1,087
New +$394K 0.06% 293

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

ClearArc Capital's ABMD Position: Q2 2019 in Review

ClearArc Capital sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 747 shares — an estimated $213K sold.

ClearArc Capital first reported a position in ABMD in Q2 2018 and held it in 4 quarters. The position peaked at $517K in Q3 2018. 483 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

  • ClearArc Capital reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
  • ClearArc Capital sold 747 Abiomed Inc shares in Q2 2019, an estimated $213K.
  • ClearArc Capital first reported a position in Abiomed Inc in Q2 2018 and held it in 4 quarters.
  • ClearArc Capital's Abiomed Inc position peaked at $517K in Q3 2018.
  • 483 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on ClearArc Capital's 13F filing for Q2 2019, filed 7 Aug 2019.